New Delhi, 14 Mar, 2015: The Medical Affairs function within the pharmaceutical sector plays an important role in new product launches, starting from the pre-launch phase and extending well beyond the launch date.
Critical aspects of launch support that Medical Affairs leaders need to focus on are early stage thought leader (TL) interaction, successful TL targeting, alignment of commercial training to demands of key stakeholders and launch resource management, according to a new study from research and consulting leader Best Practices, LLC.
“Medical Affairs’ Role in Ensuring Excellence in Product Launch,” highlights the launch activities and critical success factors that go into providing effective Medical Affairs launch support for new products.
Key study objectives included:
- Illustrating how Medical Affairs is involved in the launch process in leading Pharma and Biotech companies
- Highlighting strategies for effective thought leader (TL) segmentation and relationship management
- Understanding challenges in managing successful Medical Affairs launch support
- Identifying industry drivers regarding new product commercialization
- Exploring critical strategies for allocating Medical Affairs launch budget effectively
Findings from this primary research project provide evidence-based insights and metrics that will serve as a reference point for Medical Affairs leaders seeking to create and execute value-based launch strategies.
Best Practices, LLC engaged 28 executives from 24 leading biopharmaceutical companies within mature markets. Research analysts also conducted deep-dive interviews with five selected Medical Affairs executives.
